Statistics

Total Visits

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer16

Select a period of time:

Number of views in the range

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer7

Views

Views
May 20242
June 20241
July 20242
August 20240
September 20242
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
 

Top cities views

Views
Chicago2
Fort Worth1